James Crowe is a renowned viral immunologist and board-certified pediatric infectious diseases specialist with decades of experience in the field. He is currently the Director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center, where he has been on faculty since 1995. Dr. Crowe's laboratory focuses on microbial pathogenesis and immunity, with ongoing work with the Ebola, Marburg, Zika, chikungunya, HIV, dengue viruses, respiratory syncytial virus (RSV), influenza viruses, human metapneumovirus, rotavirus, and more. His team has developed several vaccine candidates and monoclonal antibodies, with a handful of them currently in clinical trials or late preclinical development with commercial partners. Dr. Crowe is also the founder of antibody discovery company, IDBiologics.
Throughout his career, Dr. Crowe has been the recipient of numerous awards, including the Norman J. Siegel New Member Outstanding Science Award from the American Pediatric Society, the Samuel Rosenthal Prize for Excellence in Academic Pediatrics, and the Stanley J. Korsmeyer Award (ASCI). He is an elected member of the National Academy of Medicine and the National Academy of Inventors, as well as an elected fellow of the AAAS, AAM, AAP, APS, and others. Dr. Crowe holds an MD in Medicine from the University of North Carolina at Chapel Hill School of Medicine and a BS in Premedicine from Davidson College.